Clinical Trial Software for Rare Disease Trials
Navigate small patient populations, natural history studies, and adaptive designs with a platform built for the unique challenges of rare disease trials.
Clincove's clinical trial platform is designed for the unique constraints of rare disease research. With built-in tools for global patient recruitment, natural history data integration, decentralized trial capabilities, and regulatory pathway support for orphan drug designations, our platform helps sponsors run effective trials even with very small patient populations.
Challenges in Rare Disease Trials
These are the problems that slow down rare disease research. Clincove was designed to solve them.
Small Patient Populations
Finding and enrolling eligible patients across geographically dispersed sites is the number one challenge in rare disease research. With prevalence rates often below 1 in 100,000, traditional site-based recruitment strategies simply don't work.
Natural History Data
Integrating real-world evidence and natural history data as comparators requires flexible data architecture. Many rare disease trials rely on external control arms, demanding seamless data harmonization between prospective and retrospective datasets.
Regulatory Complexity
Orphan drug designations, breakthrough therapy pathways, and adaptive designs require specialized compliance workflows. Each regulatory pathway has unique documentation requirements that must be tracked alongside the clinical data.
Patient Burden
Patients with rare diseases often travel hundreds of miles for site visits. Reducing visit frequency while maintaining data quality is essential for retention, and every unnecessary visit risks losing a patient who cannot be replaced.
How Clincove Solves It
Purpose-built features that address the specific needs of rare disease clinical trials.
Global Patient Finder
Built-in recruitment tools connected to patient registries, advocacy groups, and referral networks specifically designed for rare disease populations. Automated screening workflows help sites identify and pre-qualify candidates faster.
Natural History Integration
Import and align external natural history datasets alongside prospective trial data in a unified view. Clincove's flexible data model supports external control arms with automated CDISC-compliant mapping.
Regulatory Pathway Tools
Pre-configured templates for orphan drug, breakthrough therapy, PRIME, and accelerated approval submissions. Clincove tracks pathway-specific milestones and auto-generates the documentation packages regulators expect.
Decentralized Trial Support
eConsent, remote monitoring, ePRO, and televisit capabilities to reduce patient burden while maintaining full compliance. Patients complete assessments from home, with data flowing directly into the EDC.
Results That Matter
Measurable impact for rare disease trial teams using Clincove.
The Clincove Platform for Rare Disease
Every module works together seamlessly to power your rare disease trials from protocol to submission.
Related Therapeutic Areas
Explore how Clincove supports trials across other therapeutic areas.
Frequently Asked Questions
Common questions about rare disease clinical trial software.
Clincove integrates with patient registries, advocacy organizations, and genetic testing networks to identify potential candidates. Our platform provides site-level recruitment dashboards, automated pre-screening workflows, and referral tracking to maximize enrollment from small, geographically dispersed patient populations.
Yes. Clincove's flexible data architecture supports parallel natural history and interventional data collection. External control arm data can be imported, harmonized, and analyzed alongside prospective trial data with automated CDISC mapping and statistical comparison tools.
Clincove includes eConsent, electronic patient-reported outcomes (ePRO), remote monitoring, and televisit integration. These features reduce the travel burden on patients while maintaining regulatory compliance and data quality — critical for rare disease trials where every enrolled patient matters.